Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Mammalian sterile 20-like kinase 1 (MST1) is a homologous protein of yeast Ste20 kinase in mammals. MST1 has been extensively studied with its redefinition as a core component of the Hippo inhibition pathway in Drosophila. MST1 plays an important role in regulating embryonic growth and development, cell migration and differentiation, maintaining immune system stability, promoting apoptosis, and inhibiting tumor cell growth.
Biological Function of MST1
MST1 not only promotes the differentiation of tumor cells, but also regulates trophoblast differentiation and placental morphogenesis. Studies reported that MST1 also plays a regulatory role in cilia formation and ciliary basal localization, and this process is regulated by two separate signaling processes. MST1 plays a role in cell adhesion, endocytosis, and migration rate by mediating CCR7 (chemokine receptor 7) and DENND1C (differentially expressed in normal and neoplastic cells domain 1C). Decreased expression of MST1 inhibits phosphorylation of mature dendritic cells CCR7 and reduces cell migration by reducing the expression of Frizzled, myosin L light chain and myosin L light chain phosphatase. When stimulated, MST1 promotes phosphorylation of DENND1C (a guanine nucleotide conversion factor) in lymphocytes, thereby activating Rab13. Activated Rab13 and MST1 together promote the transfer of lymphocyte function-associated antigen 1 to the lymphocyte front, thereby increasing cell adhesion.
MST1 damages heart proteins by inhibiting autophagy. Activation of MST1 promotes the accumulation of p62 and the formation of aggregates in cardiomyocytes. MST1 exerts or promotes or inhibits autophagy by directly or indirectly phosphorylating autophagy-related proteins, the Atg8 family of proteins, providing opportunities for cardioprotection, tumor control, and immune regulation. Under the stimulation of apoptosis, MST1 can bind to GAPDH (glyceraldehyde-3-phosphate dehydrogenase), causing significant apoptosis of cardiomyocytes. The combination of MST1 with PCMT1 (protein L-isoaspartic acid (D-aspartate) o-methyltransferase 1) significantly attenuated the effect of cardiomyocytes on the apoptosis induced by hypoxia/reoxygenation. In all types of diabetes, MST1 is significantly activated, and activated MST1 induces apoptotic death by up-regulating BIM (BCL-2 homology-3 (BH3)-only) protein in beta cells, inducing disturbances in physiological functions of the human body.
Figure 1. Diabetic stimuli lead to activation of MST1, apoptosis and loss of function. (Ardestani, A. , et al. 2016)
MST1-related Signaling Pathway
Due to the homology of MST1 to Hippo, the classical pathway that starts with MST1 is called the Hippo signaling pathway. The upstream signal factors of MST1 are hMOB3 and mTORC2, and the basic substrates of MST1 include AKT, FOXO3, JNK, p38MAPK and hisone 2B. Mitotic activation of MST1 is the key to the smoothness of this signaling pathway. When MST1 division is inhibited, the Hippo pathway also becomes a pro-proliferative pathway. Studies have shown that activation of MST1 can be regulated not only by phosphorylation, but also by methylation, dimerization, promotion of acetylation of p53 (Lys382), and binding to cofactors.
Both mTOR and Hippo signaling pathways are major signaling pathways that regulate organ size and intracellular homeostasis. Chao et al. found that overexpression of MST1 and AKT in glioma cells negatively regulates the activity of AKT and mTOR, and ultimately inhibits cell proliferation and growth. In cardiomyocytes, mTORC2 phosphorylates the MST1 SARAH region Ser 438, thereby attenuating the homodimerization and kinase activity of MST1, ultimately achieving the protection of cardiac structure and function.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.